What Can an MRA Detect in the Brain?

Magnetic resonance angiography of the brain can detect a wide range of vascular abnormalities, from bulging aneurysms and narrowed arteries to tangled vessel malformations and blood clots in the veins. It does all of this without radiation and usually without an injected contrast agent, relying instead on the magnetic properties of flowing blood to generate detailed maps of cerebral vessels.¹ The technique has limitations, and it is not always the best choice for every vascular question. But the list of things it can reveal is long enough that brain MRA has become one of the most commonly ordered neurovascular studies in clinical practice.

Intracranial Aneurysms

Detecting brain aneurysms is probably the single most common reason doctors order a brain MRA. An aneurysm is a weak spot in an artery wall that balloons outward, and if it ruptures, it causes a subarachnoid hemorrhage, a type of stroke that carries high rates of disability and death. A large systematic review and meta-analysis found that MRA picks up intracranial aneurysms with a pooled sensitivity of about 95% and specificity of about 89%.² One study using a 3-Tesla scanner without contrast reported even higher numbers, with sensitivity above 99% when evaluating individual aneurysms.³

Performance does depend on aneurysm size. Tiny aneurysms under about 3 millimeters are harder to catch, and the sensitivity drops compared to larger ones. This matters because most unruptured aneurysms found incidentally are small. Still, for aneurysms in the size range where treatment decisions actually come into play, MRA performs well enough that many neurologists and neurosurgeons rely on it as a first-line diagnostic tool before considering catheter-based angiography.

One subtlety worth knowing: when MRA is used to estimate the volume of an aneurysm, it tends to underestimate the size by a modest amount, while CT angiography tends to overestimate. A comparison study found that both imaging methods had volume errors in the range of roughly 15 to 19%, but in opposite directions.⁴ That tendency toward underestimation is something radiologists account for when interpreting results.

Arterial Narrowing and Blockages

MRA can identify areas where intracranial arteries have become narrowed or completely blocked. This is relevant for people with atherosclerotic disease inside the skull, a condition that causes a substantial proportion of strokes worldwide. Diagnosis of intracranial atherosclerotic disease relies heavily on imaging the vessel lumen, and MRA is one of the standard tools for this alongside CT angiography and catheter angiography.⁵

There is an important caveat here. When compared head to head with CT angiography for detecting intracranial stenosis, MRA has lower sensitivity. One study found CT angiography caught stenosis about 98% of the time versus 70% for MRA, and for complete occlusions the gap was 100% versus 87%.⁶ MRA also has a well-known tendency to overestimate how severe a narrowing is. Turbulent or slow flow through a tight spot can cause the signal to drop out, making a moderate stenosis look worse than it really is. Clinicians are aware of this artifact and often follow up with another imaging method when the treatment decision hinges on exact stenosis measurements.

For the large arteries outside the skull, like the carotid arteries in the neck, MRA plays a complementary role. A study comparing MRA, CT angiography, and ultrasound against catheter angiography found that MRA had perfect sensitivity for detecting surgically significant carotid stenosis but lower specificity, again tending to overestimate the degree of narrowing.⁷

Stroke Evaluation

During an acute ischemic stroke, knowing where an artery is blocked and how well blood is rerouting around the blockage through collateral pathways can change treatment decisions. Dynamic MRA techniques can visualize this in real time. In a study of patients with large-vessel strokes, dynamic MRA identified the site of blockage and showed that patients with better collateral filling had smaller areas of brain damage and less severe drops in blood flow.⁸ The dynamic approach even picked up tandem blockages that standard time-of-flight MRA missed entirely.

Researchers have also developed collateral grading maps from MRA data that predict functional outcomes after a stroke, giving clinicians a tool to estimate how likely a patient is to recover well based on the robustness of their collateral circulation.⁹ In practice, CT-based imaging is still used more often in the emergency setting because it is faster and more widely available, but MRA-based stroke protocols are increasingly used at centers with the right equipment, particularly when radiation exposure is a concern or the patient needs a broader MRI workup at the same time.

Arteriovenous Malformations

Brain arteriovenous malformations are tangles of abnormal vessels where arteries connect directly to veins without the usual network of tiny capillaries in between. These carry a risk of hemorrhage and are an important finding, especially in younger patients. MRA can detect them, but how well depends on the technique used. Newer time-resolved (sometimes called “4D”) MRA methods significantly outperform the standard time-of-flight approach. In one comparison, 4D MRA correctly diagnosed about 93% of vascular lesions, while standard time-of-flight MRA only managed about 63%, with the biggest advantage being the ability to track blood flow over time and identify which veins are draining the malformation.¹⁰

Dynamic MRA can also show the full cycle of blood flow through an AVM, from the feeding arteries through the abnormal tangle to the draining veins, in a way that parallels what a catheter angiogram reveals.¹¹ That said, MRA should not be the only screening tool for certain populations. In people with hereditary hemorrhagic telangiectasia, a genetic condition that predisposes to brain AVMs, a study found that MRA alone had a sensitivity of only 50% for detecting these malformations. A full MRI exam with multiple sequence types performed far better, and the researchers concluded that MRA by itself was not reliable enough for screening in that group.¹²

Vessel Dissections

An arterial dissection happens when the inner lining of a blood vessel tears, allowing blood to seep between the layers of the wall. In the arteries supplying the brain, this can restrict blood flow and cause a stroke, particularly in younger adults. MRA combined with standard MRI has been shown to have high sensitivity and specificity for detecting dissections in both the internal carotid and vertebral arteries. MRI reveals the characteristic blood clot within the vessel wall, while MRA shows the resulting loss or reduction of blood flow through the damaged segment.¹³ For follow-up after a dissection diagnosis, repeated MRA scans can track whether the vessel is healing without needing to go back to catheter angiography.

Venous Sinus Thrombosis

Brain MRA is not limited to arteries. Magnetic resonance venography, a variant of the technique tuned to veins rather than arteries, is widely used to evaluate cerebral venous sinus thrombosis, a condition where blood clots form in the large venous channels that drain blood from the brain. A meta-analysis pooling data from nearly 2,000 cases found that MR venography had a pooled sensitivity of about 86% and specificity of about 94% for this diagnosis.¹⁴ In pediatric patients, MR venography has been considered the technique of choice for evaluating dural sinus and cerebral venous thrombosis, in part because it avoids the radiation exposure of CT-based alternatives.¹⁵

Inflammatory and Unusual Vessel Diseases

Standard MRA shows the inside of the vessel lumen, so it can detect narrowing, but it cannot always explain why a vessel is narrowed. A newer technique called vessel wall MRI goes further by imaging the vessel wall itself. This approach can help distinguish between atherosclerotic plaque, inflammation from vasculitis, and rarer conditions like Moyamoya disease and reversible cerebral vasoconstriction syndrome.¹⁶

Moyamoya disease illustrates why this matters. In Moyamoya, the large arteries at the base of the brain gradually narrow and close off, and the body compensates by growing a cloud of tiny collateral vessels. Standard MRA can reveal the narrowing, but vessel wall imaging adds another layer of information. Early studies found that Moyamoya vessels lacked the wall thickening and enhancement typically seen in atherosclerosis, while later research found enhancement was more common than expected. The science is still being sorted out, but the clinical takeaway is that vessel wall imaging can help separate Moyamoya from other look-alike conditions at the carotid artery terminus.¹⁷

Low-Flow Vascular Lesions and Cavernous Malformations

Not every abnormal collection of vessels in the brain has fast, dramatic blood flow. Developmental venous anomalies, the most common type of vascular malformation in the brain, carry slow-flowing blood and are usually harmless. MRA can detect most of them, though reading both the raw image slices and the processed images is important to avoid missing smaller ones. One study found MRA was diagnostic in about 80% of developmental venous anomalies.¹⁸ These anomalies often co-exist with cavernous malformations, which are clusters of thin-walled, blood-filled spaces that do not show up well on flow-based MRA at all. For cavernomas, susceptibility-weighted MRI sequences are far more sensitive, and ultra-high-field 7-Tesla scanners pick up significantly more lesions than standard 3-Tesla machines.¹⁹ This is a useful reminder that MRA, despite its capabilities, does not catch everything vascular in the brain. Some lesions need different MRI sequences or imaging techniques entirely.

Incidental Findings and the Screening Question

Because brain MRA is so sensitive to aneurysms, it sometimes finds them when nobody was looking. Unruptured intracranial aneurysms show up in roughly 2 to 3% of the general population, and as imaging technology has improved, the detection rate has climbed. A large study tracking trends over 15 years found that the detection rate of asymptomatic unruptured aneurysms rose from about 1.7% in the 2005–2009 period to 3.4% in 2015–2019, with the most pronounced increase among people over 70.²⁰

Finding more aneurysms sounds like progress, but it creates a dilemma. Most small aneurysms never rupture. The annual growth rate is around 3% per aneurysm-year, and the rupture risk for aneurysms that are not growing is very low, roughly 0.1% per year. Larger or irregularly shaped aneurysms carry much higher risk.²¹ Once an aneurysm is discovered, the person typically enters a surveillance program of follow-up imaging, which comes with its own costs and psychological burden. Research on patients followed with MRA more than four years after aneurysm coiling found that about half reported problems with anxiety or depression at the time of their follow-up scan.²²

For the general population, screening everyone with MRA is not cost-effective. Economic modeling has confirmed this repeatedly, with the cost per quality-adjusted life-year far exceeding standard thresholds for worthwhile healthcare spending.²³ The picture changes for people with a family history. Screening individuals who have two or more first-degree relatives affected by aneurysms or subarachnoid hemorrhage is cost-effective, and the optimal strategy appears to be screening at around age 40 and again at 55.²⁴ For people with just one affected relative, the economics are more borderline.²⁵

Monitoring After Treatment

Brain MRA has an important role after treatment, not just before it. For aneurysms that have been treated with coiling, where tiny metal coils are packed inside the aneurysm to block blood flow, follow-up MRA can check whether the aneurysm has stayed sealed or is refilling. Contrast-enhanced MRA has been shown to be accurate for this purpose even when a stent is also present, which can cause artifacts with other imaging methods.²⁶ The non-invasive nature of MRA makes it practical for repeated surveillance over years, avoiding the small but real risks of catheter-based angiography each time.

Children’s Brains

In pediatric patients, MRA is particularly attractive because it avoids radiation. Children’s brains are more sensitive to radiation-related harm, and many of the conditions being evaluated, such as vascular malformations associated with congenital brain abnormalities, require repeated imaging over time. MRA and MR venography have been found most useful for evaluating vascular distortions related to congenital brain malformations and intracranial tumors in children.¹⁵ For childhood arterial strokes, MRA provides enough detail for an adequate initial evaluation of the arterial disease, though its tendency to overestimate stenosis means follow-up imaging may sometimes be necessary to confirm borderline findings.²⁷

Where MRA Falls Short

Understanding the limitations is just as important as knowing the capabilities. The most widely used form of brain MRA, time-of-flight imaging, depends on fresh blood flowing into the imaging area. Anything that disrupts that flow signal creates problems. Slow-moving blood in a severely narrowed vessel can lose its signal entirely, making partial blockages look like complete ones. Very small vessels at the periphery of the brain’s arterial tree produce weak signals that may not be visible. Turbulent flow at branch points or near narrowings can also cause signal dropout and ghost-like artifacts in the image.

Phase-contrast MRA, a different technique, can measure actual blood flow velocities and volume, which is useful for specific clinical questions like assessing how much blood is flowing through a particular vessel.²⁸ But it is slower and less commonly used for routine screening. Each MRA technique has trade-offs, and radiologists often combine several in a single exam to get the most complete picture.

How Ultra-High-Field Scanners and AI Are Expanding What MRA Can See

Standard clinical MRA runs at field strengths of 1.5 or 3 Tesla. Moving to 7 Tesla enables visualization of much smaller intracranial vessels that are invisible at lower field strengths, and adding a contrast agent at 7T can push the resolution even further into distal arteries, veins, and venules.²⁹ Researchers have used 7-Tesla MRA to clearly image the lenticulostriate arteries, tiny perforating branches deep in the brain that are involved in a common type of small-vessel stroke but have historically been too small to see with standard imaging.³⁰

Artificial intelligence is also making a difference, even on standard scanners. Deep-learning image reconstruction applied to 1.5-Tesla MRA has been shown to reduce image noise and provide clearer depiction of both large and small intracranial arteries without adding scan time.³¹ Super-resolution deep-learning methods can increase the effective spatial resolution of MRA images without the usual penalty of longer scan times or noisier images.³² A preliminary study using compressed-sensing deep learning showed significantly better visualization of lenticulostriate arteries compared to conventional reconstruction, suggesting these tiny vessels may become routinely visible even without ultra-high-field hardware.³³ These advances are gradually narrowing the gap between what MRA can resolve and what has traditionally required invasive catheter-based studies.